Q1 EPS Estimate for UnitedHealth Group Raised by Analyst

UnitedHealth Group Incorporated (NYSE:UNH) – Zacks Research raised their Q1 2027 EPS estimates for shares of UnitedHealth Group in a research report issued on Tuesday, August 18th. Zacks Research analyst Team now forecasts that the healthcare conglomerate will post earnings of $7.12 per share for the quarter, up from their previous estimate of $7.05. Zacks Research currently has a “Strong-Buy” rating on the stock. The consensus estimate for UnitedHealth Group’s current full-year earnings is $19.69 per share. Zacks Research also issued estimates for UnitedHealth Group’s Q2 2027 earnings at $6.35 EPS, FY2027 earnings at $22.28 EPS and FY2028 earnings at $25.74 EPS.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, beating analysts’ consensus estimates of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business had revenue of $112.03 billion for the quarter, compared to analysts’ expectations of $110.81 billion. During the same period in the previous year, the company posted $4.08 EPS. The company’s quarterly revenue was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS.

UNH has been the topic of several other reports. Wells Fargo & Company increased their price target on shares of UnitedHealth Group from $397.00 to $485.00 and gave the company an “overweight” rating in a research report on Monday, July 13th. Royal Bank Of Canada increased their price objective on UnitedHealth Group from $463.00 to $478.00 and gave the company an “outperform” rating in a research note on Friday, July 17th. Argus raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $400.00 target price for the company in a research note on Wednesday, April 22nd. KeyCorp lifted their price target on shares of UnitedHealth Group from $400.00 to $475.00 and gave the stock an “overweight” rating in a report on Tuesday, July 14th. Finally, Truist Financial upped their price objective on shares of UnitedHealth Group from $440.00 to $480.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Two research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $455.92.

UnitedHealth Group Trading Down 0.4%

NYSE:UNH opened at $394.16 on Wednesday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.78. The stock has a fifty day moving average price of $415.15 and a two-hundred day moving average price of $354.35. UnitedHealth Group has a 1 year low of $255.96 and a 1 year high of $461.62. The stock has a market capitalization of $353.80 billion, a price-to-earnings ratio of 25.36, a PEG ratio of 1.40 and a beta of 0.62.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th will be paid a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date is Monday, September 14th. UnitedHealth Group’s dividend payout ratio (DPR) is 59.72%.

Insiders Place Their Bets

In related news, CEO Patrick Hugh Conway sold 500 shares of the firm’s stock in a transaction on Wednesday, August 5th. The stock was sold at an average price of $410.00, for a total transaction of $205,000.00. Following the transaction, the chief executive officer directly owned 16,497 shares in the company, valued at $6,763,770. This trade represents a 2.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.19% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On UnitedHealth Group

A number of hedge funds have recently modified their holdings of UNH. Sarver Vrooman Wealth Advisors acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at about $25,000. Anfield Capital Management LLC increased its position in shares of UnitedHealth Group by 220.0% during the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock valued at $26,000 after purchasing an additional 55 shares during the period. Joseph Group Capital Management bought a new stake in shares of UnitedHealth Group in the 4th quarter worth about $27,000. Nalls Sherbakoff Group LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at about $27,000. Finally, Lifetime Wealth Management P.C. bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $29,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.